This Overlooked Warren Buffett Stock Is Absurdly Cheap Right Now

Constellation Brands reported fiscal 2026 net income of almost $1.7 billion, rebounding from an $81 million loss a year earlier after a $2.8 billion impairment rolled off. Despite a 10% overall sales decline and a 3% drop in beer revenue, the company increased its annual dividend to $4.12 per share, completed a $924 million buyback, and guided to flat sales growth at the midpoint for fiscal 2027. The stock also trades at 17x earnings versus 29x for the S&P 500, supporting the contrarian recovery case.

Analysis

The market is likely pricing STZ as a “value recovery” rather than a structural turnaround, but the more important dynamic is capital efficiency under revenue stagnation. If beer can hold share while wine/spirits shrink into a smaller drag, free cash flow can improve faster than top line, and that matters more than headline sales for a business with a growing dividend and active buyback. The key second-order effect is that management is implicitly telling the market the balance sheet can absorb a lower-growth profile without forcing a payout reset, which should support multiple stabilization.

The bearish case is that the current optimism may be front-running an earnings base that is easier to beat than to sustain. A flat-sales guide after a down year can look like inflection, but if beer volumes are only stabilizing because pricing offsets unit softness, the next leg of margin support could prove temporary once promotional intensity rises. Also, the “contrarian” setup only works if investor concern is about sentiment, not a multi-year category erosion; if younger cohort behavior continues to shift away from alcohol, the terminal multiple should compress, not expand.

The real competitor risk is not another spirits brand but adjacent share capture from premium nonalcoholic beverages, cannabis substitutes where legal, and at-home moderation trends that alter channel mix. That creates a slow-burn headwind that won’t show up in one quarter, but over 12-24 months can cap both volume and pricing power. The near-term catalyst is management execution under the new CEO: if the market sees disciplined capital allocation plus no deterioration in beer mix, the stock can rerate. If not, the yield/value story becomes a trap.

Buffett ownership is helping because it converts STZ into a perceived “quality value” name, but consensus may be overestimating how much sponsor-like support can offset category pressure. The better framing is that STZ is a cash-return story with optionality, not a clean secular compounder. That makes the setup attractive tactically, but fragile if investors start demanding evidence of volume inflection rather than accepting financial engineering alone.

Key Decisions for Investors

• Long STZ for 3-6 months into confirmation of beer stabilization; target a low-teens upside rerating if guidance holds, with downside limited to high-single-digit percentage if the yield floor remains intact.
• Use STZ calls rather than stock if entering ahead of the next earnings print; the best setup is a skew-friendly event trade where downside is capped and a clean beat/raise can re-rate the multiple quickly.
• Pair long STZ / short a basket of more cyclical consumer discretionary names over 1-2 quarters; STZ’s cash return profile should outperform if risk appetite stays selective and investors favor defensive yield.
• Trim or avoid adding after a sharp post-guidance rally unless volume data improves; the risk/reward worsens materially if the move is driven by multiple expansion without evidence of sustained demand.
• Monitor management commentary on pricing vs volume over the next 1-2 quarters; if volume deterioration re-accelerates, exit the long and fade the name on any valuation-driven bounce.